Clinical Trial Update: Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites [Phase 1]

View source ↗

Summary

Phase 1 PK study describing the absorption, distribution, metabolism and excretion of [14C]-labeled BIA 5-453 and its metabolites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• BIA 5-453

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension, Congestive Heart Failure | Phase 1 | Status: COMPLETED